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1. Introduction
Rhodococcus equi is a ubiquitous, soil bacterium which
has evolved into an opportunistic pathogen through
the acquisition of an 80 kbp virulence plasmid. Pathogenic
R. equi infect different domesticated animal hosts
(pigs, sheep and cattle) but are most frequently associated
with bronchopneumonial disease in very young foals. It is
also an emerging human pathogen, affecting immuno-
compromised individuals. In foals, disease is transmitted
through inhalation of contaminated dust particles, leading
to severe lung infection which eventually spreads to the
gut and other areas (Meijer and Prescott, 2004; Va´zquez-
Boland et al., 2013). Excretion of contaminated faeces
completes the infection cycle. Clinical manifestations of
R. equi lung infection include bronchitis and pulmonary
lesions (Prescott, 1991), and in the absence of treatment
mortality rates are in the region of 80% (Muscatello et al.,
2007). Thus, R. equi represents a major threat to foal health
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A B S T R A C T
Virulence and host range in Rhodococcus equi depends on the variable pathogenicity island
of their virulence plasmids. Notable gene products are a family of small secreted virulence-
associated proteins (Vaps) that are critical to intramacrophagic proliferation. Equine-
adapted strains, which cause severe pyogranulomatous pneumonia in foals, produce a
cell-associated VapA that is necessary for virulence, alongside ﬁve other secreted
homologues. In the absence of biochemical insight, attention has turned to the structures
of these proteins to develop a functional hypothesis. Recent studies have described crystal
structures for VapD and a truncate of the VapA orthologue of porcine-adapted strains,
VapB. Here, we crystallised the full-length VapG and determined its structure by
molecular replacement. Electron density corresponding to the N-terminal domain was not
visible suggesting that it is disordered. The protein core adopted a compact elliptical, anti-
parallel b-barrel fold with b1–b2–b3–b8–b5–b6–b7–b4 topology decorated by a single
peripheral a-helix unique to this family. The high glycine content of the protein allows
close packing of secondary structural elements. Topologically, the surface has no
indentations that indicate a nexus for molecular interactions. The distribution of polar and
apolar groups on the surface of VapG is markedly uneven. One-third of the surface is
dominated by exposed apolar side-chains, with no ionisable and only four polar side-
chains exposed, giving rise to an expansive ﬂat hydrophobic surface. Other surface regions
are more polar, especially on or near the a-helix and a belt around the centre of the
b-barrel. Possible functional signiﬁcance of these recent structures is discussed.
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worldwide and has a signiﬁcant economic impact on the
horse breeding industry. Current treatments for R. equi
infections involve combination drug therapies with
rifampin and macrolides such as clarithromycin (Gigue`re
et al., 2011). These treatments can be protracted and
expensive, and are not always successful. Furthermore,
antibiotic resistant strains are emerging (Andersen et al.,
1997; Asoh et al., 2003). While vaccine trials are on-going
and making headway (Hooper-McGrevy et al., 2005;
Dawson et al., 2010; Whitehead et al., 2012), there are
still no commercially available vaccines, and research
investigations are now focussing on the mechanism of
pathogenicity induced by R. equi in order to provide
insights which may ultimately lead to better treatments
for infection.
R. equi is a Gram-positive coccobacillus with a lipid-rich
cell envelope characteristic of the mycolata, a group of
acid-fast actinomycetes that includes Mycobacterium,
Corynebacterium and Nocardia species. It metabolises a
wide range of organic and inorganic compounds and
thrives on the mixture of organic compounds found in
animal manure. Virulent R. equi enter alveolar macro-
phages by receptor-mediated phagocytosis and survive
and proliferate in phagosomes. The bacterium has the
ability to halt phagosome maturation prior to the late
endocytic stage, thereby protecting it from normal
bacteriocidal factors and allowing it to proliferate (Fer-
nandez-Mora et al., 2005). Virulence of R. equi strains is
strictly associated with the possession of an 80 kbp
plasmid (Takai et al., 1991b; Tkachuk-Saad and Prescott,
[(Fig._1)TD$FIG]
Fig. 1. The virulence genes/proteins of R. equi. (A) The 21.3 kb pathogenicity island region of the equine type R. equi plasmid pVAPA1037. The genes encoding
the homologous virulence associated proteins Vaps A, C, D, E, G, H are shown in bluewith a one letter label. The pseudogenes vapF, vapI and vapX are shown
in turquoise. The genes encoding the transcriptional regulators virR (a LysR type transcriptional regulator) and virS (an orphan two-component system
response regulator) are coloured in orange. Expression of vapA appears to be controlled indirectly by VirR in response to temperatures above 30 8C and
acidic pH by production of VirS (green arrow) (Russell et al., 2004), which is required for transcription of the vapAIC(orfAB)D operon (purple arrow) (Kakuda
et al., 2014); the small uncharacterised ORFs (orfAB) that lie between vapC and vapD are not shown for clarity. The promoter associated with the vcgABC
operon (uncharacterised vap co-expressed genes) shares homology with the vapA promoter (Miranda-CasoLuengo et al., 2011) suggesting that a similar
mode of regulationmay operate. Observed transcripts are related as orange arrows (Byrne et al., 2007, 2008; Kakuda et al., 2014;Miranda-CasoLuengo et al.,
2011). (B) Comparison of the amino acid sequences of the Vap proteins of the R. equi horse virulence plasmid together with VapB form the porcine virulence
plasmid. The sequences were aligned in CLUSTALW (Thompson et al., 1994) and displayed together with the secondary structure elements of VapG using
the programme ESPRIPT (Robert and Gouet, 2014). Invariant residues in the alignment are shown inwhite type on a red background; conserved residues are
in blue boxes (For interpretation of the colour information in this ﬁgure legend, the reader is referred to the web version of the article.).
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1991). Plasmid-cured strains do not proliferate in macro-
phages, are cleared in murine models of infection, and are
avirulent in foals (Hondalus andMosser, 1994;Wada et al.,
1997; Gigue`re et al., 1999). The virulence plasmid harbours
a pathogenicity island (Fig. 1A) containing 26 coding
sequences including that for the virulence-associated
protein A (VapA). VapA is an 20 kDa immunodominant
protein present in clinical isolates of infected foals (Takai
et al., 1991a,b; Tan et al., 1995). A strain of R. equi with a
vapA deletionmutation was shown to be unable to grow in
macrophages and to be incapable of establishing infection
inmice pointing to an essential role in virulence (Jain et al.,
2003). However, plasmid-encoded factors other than VapA
are needed for virulence since expression of wild type
levels of VapA in otherwise virulent, plasmid-cured strains
of R. equi does not restore virulence in mice or foals
(Gigue`re et al., 1999). Similarly, in plasmid pathogenicity
island-deleted strains of R. equi, constitutive expression of
vapA could delay clearance of the pathogen from mice but
it did not restore virulence (Coulson et al., 2010). Thus vapA
is necessary but not sufﬁcient for virulence and other
pathogenicity island-encoded factors are required.
Also encoded on the pathogenicity island are a set of
virulence-associated proteins highly homologous to VapA;
VapC, VapD, VapE, VapG, and VapH (Fig. 1A). In addition,
there are three pseudogenes vapF, vapI and vapXwhich are
not thought to code for functional proteins since they
harbour substantial truncations and/or frameshifts. The
role of these additional vap genes andwhether they encode
proteins with overlapping or redundant functions is not
established. The available evidence indicates that these
genes are not essential for virulence, at least in mice, since
a mutant deleted for vapA, -C, -D, -E is complemented by
vapA expressed in trans (Jain et al., 2003). The vap genes are
induced by elevated temperature, starvation of various
metals, and low pH, conditions likely to be encountered in
the macrophage (Benoit et al., 2001; Ren and Prescott,
2003). vapA expression is dependent on two pathogenicity
island factors, virR, which encodes a LysR type transcrip-
tional regulator and virS (orf8) which encodes an orphan
two-component system response regulator (Fig. 1A) (Ren
and Prescott, 2003; Russell et al., 2004). Each of the vap
genes encodes a secretion signal peptide consistent with
the translocation of their gene products to the outside of
the cell where many have been detected by immunoblot-
ting of R. equi culture supernatants (Byrne et al., 2001). By
contrast, VapA appears to be retained on the bacterial cell
surface (Takai et al., 1992).
In order to provide a framework for a new set of studies
to investigate the critical function(s) of VapA and its role in
R. equi virulence, we and others have sought to determine
its three-dimensional structure. However, crystals of VapA
have proved elusive and efforts were directed towards
homologous Vap proteins. The crystal structures of two
Vap proteins, VapB whose gene resides on a plasmid
present in R. equi isolates from pigs (Geerds et al., 2014)
and VapD (Whittingham et al., 2014) have been deter-
mined. An alignment of the sequences of the six plasmid-
encoded Vap proteins from horse isolates of R. equi
together with VapB from pig isolates is presented in
Fig. 1B. The structures revealed that the highly conserved
C-terminal residues form an eight-stranded b-barrel. In
the case of VapD, circular dichroism as well as crystallo-
graphic data indicated that the N-terminal region of the
protein, whose sequence is poorly conserved across the
Vap family, is intrinsically disordered. Here, we are
concerned with a third virulence-associated protein
VapG. vapG expression is known to be highly up-regulated
in R. equi infectedmacrophages and in the lungs of infected
foals. However, deletion mutagenesis showed VapG to be
dispensible for growth of the pathogen in macrophages
and in vivo in mice (Coulson et al., 2010). In this work, we
present the crystal structure of VapG and compare its
structure to those of VapB and VapD. The results are
discussed in terms of possible functions of the Vap
proteins.
2. Materials and methods
2.1. Protein production and puriﬁcation
VapG was cloned as a commercial service by Euroﬁns
Operon in pET23b. Native R. equi sequence was used and
fused directly with restriction sites for NdeI (50, with the
ATG of the restriction site representing the start codon)
and EcoRI (30, directly after the last codon) to form
pET23-matvapG.
Transformants of Escherichia coli BL21 (DE3) carrying
pET23-vapG were grown overnight in 10ml LB broth
supplemented with 100mgml1 ampicillin at 37 8C with
shaking at 200 rpm. This overnight preculture was used to
inoculate 1 l of Terriﬁc broth (100mgml1 ampicillin) and
grown at 37 8C to an OD600 of 0.5–0.7 at 180 rpm, 37 8C. The
culture was cooled to 16 8C and recombinant gene
expression was induced by the addition of 1mM IPTG;
cultures were held at 16 8C overnight before harvesting by
centrifugation at 2880 g for 10min at 4 8C. Pelleted cells
were re-suspended to 10ml/g in 0.02M Tris–HCl (pH 7.4,
containing 0.5M NaCl, 0.03M imidazole) and lysed by
exposing resuspended cells (in 5ml aliquots) to 6 cycles of
10 s sonication/10 s cooling with amplitude setting at 10m
using a MSE Soniprep 150 ultrasonic disintegrator. The
lysate was clariﬁed by centrifugation at 27,000 g for
30min at 4 8C.
Recombinant protein was puriﬁed from the clariﬁed
lysate via a two-step process using Immobilised Metal
Afﬁnity Chromatography (IMAC) on Ni2+-charged Chelat-
ing Sepharose Fast Flow resin (GE healthcare Life Sciences)
followed by anion-exchange chromatography on HiTrap
Q HP. Firstly, the IMAC column (10ml bed volume) was
equilibrated with 200ml of 0.02M Tris–HCl (pH 7.4)
containing 0.03M imidazole, 0.5MNaCl (otherwise known
as equilibration buffer) at a ﬂow rate of 5ml/min (for
20min). The clariﬁed lysate was loaded onto the column at
a ﬂow rate of 2ml/min and washed with the equilibration
buffer at a ﬂow rate of 4ml/min for 25min. Elution of
bound protein was effected via an linear gradient if
imidazole concentration (from 0.03 to 0.5M) at a ﬂow rate
of 4ml/min. Eluate was collected in 4ml fractions. The
composition of each fraction was analysed on SDS-PAGE to
identify those containing VapG.
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Fractions containing VapG were pooled and concen-
trated to about 0.5ml by centrifuging at 2880 g, 4 8C
using a 10 kDa Vivaspin 20 Centrifugal Concentrator
(Sartorius Stedim Biotech, France). This process was
repeated three times with 20ml of ice-cold 0.02M Tris–
HCl (pH 8.0) to remove imidazole and NaCl. After the ﬁnal
concentration, the sample was diluted to a ﬁnal volume of
20ml in the same buffer and subjected to anion exchange
chromatography on a 5ml bed volume HiTrap Q HP
column equilibrated with 0.02M Tris–HCl (pH 8.0) at a
ﬂow rate of 5ml/min. The VapG-enriched sample was
applied at a ﬂow rate of 2ml/min and eluted with 0.02M
Tris–HCl, 1M NaCl (pH 8.0) at a ﬂow rate of 4ml/min in a
linear gradient using 0.02M Tris–HCl (pH 8.0) as the
diluent.
2.2. Size-exclusion chromatography with multi-angle laser
light scattering (SEC-MALLS)
For the determination of the oligomeric state of VapG,
the protein was analysed by SEC-MALLS. Samples of
protein at concentrations of 4mg/ml were loaded onto a
Superdex S75 10/300 gel-ﬁltration column equilibrated at
0.5mlmin1 with a mobile phase consisting of 50mM
Tris–HCl pH 8.0, 150mM NaCl. The eluate was passed
through an SPD20A UV–vis detector, a Wyatt Dawn
HELEOS-II 18-angle light-scattering detector and a Wyatt
Optilab rEX refractive index monitor with the system
driven by a ShimadzuHPLC system comprising an LC-20AD
pump. The data were processed and molecular masses
were calculated using the Astra V software (Wyatt) as
described previously (Colledge et al., 2011).
2.3. Protein crystallisation, data collection, structure solution
and reﬁnement
Crystals were obtained using a protein solution
consisting of VapG at 30mgml1 in 10mM Tris–HCl (pH
7.5), 10mM NaCl. The crystals grew at 18 8C by hanging
drop vapour diffusion against a reservoir solution contain-
ing 0.3M potassium chloride, 20% PEG 3350, originating
from the Peg/Ion screen (Hampton Research). A crystal of
approximate dimensions 400mm 400mm 400mm
was vitriﬁed in cryoprotectant solution (30% glycerol,
70% reservoir) and X-ray diffraction data were collected at
100 K at the Diamond Light Source experimental station
I02. Data were integrated using XDS (Kabsch, 2010) and
scaled/merged with Aimless (Evans, 2011). The structure of
VapG was solved by molecular replacement with the
program MOLREP (Vagin and Teplykov, 2010) using a
family-related structure VapD (PDB code 4csb, Whitting-
ham et al., 2014) as a search model, this sharing 60% amino
acid sequence identity with VapG (Fig. 1B). Two solutions
were found equating to two molecules of VapG per
asymmetric unit. The resulting model was reﬁned using
maximum likelihood methods implemented in REFMAC5
(Murshudov et al., 2011) with 5% of the total data excluded
from the reﬁnement for the purpose of R free calculations.
This procedurewas interspersedwithmanual corrections to
the model using COOT (Emsley et al., 2010) in conjunction
with 2Fo Fc and Fo Fc electron density maps.
During reﬁnement, elongated peaks of positive differ-
ence electron density appeared in two independent
locations in the asymmetric unit. These peaks had the
appearance of additional protein chains or peptides bound
between the protein molecules: in one location a sequence
of three histidines was built and successfully reﬁned; in
the other the sequence ALAA was built. It was concluded
that these elements formed parts of the C-terminal afﬁnity
tags from the two VapG molecules, with the ALAA
corresponding to the tag sequence KLAA in one molecule
and AALE in its symmetrymate. Another striking feature in
the electron density maps was a strong metal ion peak
located at the centre of a cluster of main chain and side
chains oxygen donors from residues 107 to 114 of
molecule A. The coordination distances ranged from
2.7 to 3.1 A˚ which was consistent with a potassium ion
(Harding, 2002). Although other metal ion candidates
(calcium and magnesium) were tested out in reﬁnement,
potassium was the only one which reﬁned satisfactorily.
Furthermore, X-ray absorption analysis of a single crystal
revealed no othermetal ions present apart frompotassium,
which was a crystallisation component. Reﬁnement
statistics and structural information are listed in Table 1.
2.4. Structure analysis
During analysis of the structure, multiple sequence
alignment was performed using CLUSTAL-W (Thompson
et al., 1994) and displayed using ESPript 3.0 (Robert and
Gouet, 2014). Three dimensional structural alignments
were made using secondary-structure matching (Krissinel
and Henrick, 2004) implemented in COOT (Emsley et al.,
2010). All ﬁgures were generated using CCP4mg (McNi-
cholas et al., 2011).
Table 1
Crystallographic data collection and reﬁnement statistics.
Data collection and processing statistics
Diamond beamline/wavelength (A˚) I02/0.9795
Space group/cell dimensions (A˚) P41212/a = 44.6, c = 259.7
Resolution limits (A˚)a 31.50–1.80 (1.85–1.80)
No. unique reﬂections 24,979
Completeness (%)a 98.1 (83.4)
Multiplicitya 11.4 (7.2)
Rmerge
a,b 0.043 (0.674)
I/sIa 31.4 (2.6)
Reﬁnement statistics
Rcryst
c/Rfree
d 0.2009/0.2362
rmsD bond length (1–2) (A˚)e 0.021 (0.019)
rmsD angles (8)e 1.893 (1.925)
rmsD chiral volumes (A˚3)e 0.126 (0.200)
Average B (A˚2): protein/waters
and K+ ion
31.55/38.02
Ramachandran outliers (%) 0
a Highest resolution shell statistics given in parentheses.
b Rmerge =
P
hkl
P
i|Ii hIi|/
P
hkl
P
ihIi, where Ii is the intensity of the ith
measurement of a reﬂection with indexes hkl and hIi is the statistically
weighted average reﬂection intensity.
c Rcryst =
PjjFoj  jFcjj/
PjFoj, where Fo and Fc are the observed and
calculated structure factor amplitudes, respectively.
d R-free is the Rcryst calculated with 5% of the reﬂections chosen at
random and omitted from reﬁnement.
e Average geometric restraints given in parentheses.
T. Okoko et al. / Veterinary Microbiology 179 (2015) 42–52 45
3. Results
3.1. Characterisation of recombinant VapG
The puriﬁed recombinant VapG protein was analysed
by size exclusion chromatography with multi-angle laser
light scattering. Here the protein is fractionated on a gel
ﬁltration column and the absorbance at 280 nm and the
refractive index of the eluate are monitored together with
themulti-angle light scattering of the sample. This enables
the weight average molecular weight (Mw) of the eluting
protein to be calculated continuously. The data from this
experiment are shown in Fig. 2. Applying this analysis, we
determined a molecular mass of 15.2 kDa for mature VapG
fused to a C-terminal LEHHHHHH sequence. This compares
with the mass calculated from the amino acid sequence of
16.0 kDa. It is clear therefore that VapG is a monomer.
3.2. Crystal structure of VapG
The recombinant protein used to obtain crystals
comprised the mature VapG polypeptide (Fig. 1B) fused
to a 20-residue sequence (PNSSSVDKLAAALEHHHHHH) at
the C-terminus of the protein which included a poly-
histidine afﬁnity tag. As described earlier, the extended
fusion portion of the protein formed intermolecular
contacts critical for crystal growth. The asymmetric unit
of the crystal contained two independent VapG molecules
(molecules A and B). The reﬁned structure consists of
residues 42–147 of chain A and 41–147 of chain B. The low
complexity N-terminal regions (residues up to and
including Asn41 of chain A, and Ala40 of chain B) were
not visible in the electron density maps. These residues
were assumed, therefore, to be disordered. The same is true
for most of the C-terminal tags (residues Asn148-His166)
though short segments at the centre of these sequences
were visible, mediating lattice contacts.
The A and the Bmolecules are virtually identical in fold.
Following superposition of the two chains by least squares
methods, the root mean squared deviation (rmsD) in
corresponding Ca atom positions is 0.45 A˚. Each molecule
consists of eight b-strands and a single a-helix. The
strands assemble to form a compact, anti-parallelb-barrel,
which is elliptical in cross section (Fig. 3), and which has a
b1–b2–b3–b8–b5–b6–b7–b4 topology. The N- and C-
termini are each at the lower end of the barrel when it is
viewed as in Fig. 3A and B. Thusb-turns link strands which
are adjacent in the barrel;b1 andb2, andb5 andb6, at the
top of the molecule and b2 and b3, and b6 and b7, at the
base of the molecule. The remaining inter-strand connec-
tions,b3–b4 andb7–b8 at the top of themolecule (Fig. 3C)
and b4–b5 at the base (Fig. 3D) cross-over the barrel
effectively acting as caps that close off its ends. The b4–b5
connector contains the nine-residue a-helix. The short
turns between strands and their close packing give the
upper end of the molecule a smooth rounded surface,
compared to the base where the b2–b3 and b6–b7 turns
protrude outwards from themolecule to accommodate the
a-helix.
The VapG protein fold described here was observed
earlier for VapB and VapD and can be described as
consisting of two Greek-key motifs separated by a small
a-helix (Geerds et al., 2014; Whittingham et al., 2014).
Despite the numerous occurrences of eight stranded
b-barrel structures in the protein data bank (www.ebi.
ac.uk/pdbe), the b1–b2–b3–b8–b5–b6–b7–b4 topology
has not been observed elsewhere and it appears, therefore,
that the Vap proteins are the deﬁning members of a novel
fold family.
Another interesting surface feature of the protein is a
potassium ion which is bound at the head of the loop
between b-strands 5 and 6 in molecule A (Fig. 4). The ion
has a distorted octahedral coordination sphere consisting
of the side chain oxygen atoms of residues Asn106 and
Asn113 (both conserved), the main chain oxygen atoms of
three residues Asn106, Val108 and Tyr111 and a water
molecule (Fig. 4). The equivalent site in molecule B does
not contain a potassium ion as this site is occluded by the
side chain of Ile76 of molecule A, which forms a crystal
contact. This tight packing arrangement appears to be the
cause of minor chain distortions in this loop in molecule
B compared to molecule A.
3.3. The protein core
The core of VapG consists of densely packed, hydro-
phobic side chains many of which are contributed by
alternate residues of the b-strands (Fig. 5A). A series of
conserved aromatic side chains form an internal ladder
that dominates one half of the protein core. Notable among
the conserved residues is Trp145, which is at the heart of the
protein core and surrounded by side chains of Leu60, Val62,
Phe69, Leu88, Leu96, Tyr97 and Phe116 emanating from six
different elements of secondary structure including the
a-helix to which Trp145 makes extensive contacts.
Curiously, the opposing half of the core is dominated by
aliphatic side chains and devoid of aromatic groups
(Fig. 5A). Evidently, this arrangement facilitates close
packing in the protein interior and presumably enhances
the stability of the barrel.
[(Fig._2)TD$FIG]
Fig. 2. Size exclusion chromatography with multi-angle laser light
scattering (SEC-MALLS) analysis of VapG. The refractive index (RI) of the
eluate from a Superdex S75 column is plotted as a function of time (blue
trace). Over the peak region, the molecular weight (MW) of the species
(green line) in the eluate is calculated from the light scattering
measurements (For interpretation of the colour information in this
ﬁgure legend, the reader is referred to the web version of the article.).
T. Okoko et al. / Veterinary Microbiology 179 (2015) 42–5246
The indole>NH of Trp145 forms a hydrogen bond to the
hydroxyl of Thr100, the only polar interaction in this region
of the protein core. In the upper region of the core, the
amide of the Gln56 side chain is at the centre of a local
network of hydrogen bonds involving Ser73, Ser77, Tyr105
and a partially buried water molecule. The Gln56 to Tyr105
interaction, which links strands 2 and 5 is conserved in
VapB and VapD and presumably VapA, although it is
[(Fig._3)TD$FIG]
Fig. 3. The chain topology in VapG. (A) and (B) Approximately orthogonal views of the VapG chain represented as a ribbon trace colour-ramped from the
N-terminus (blue) to the C-terminus (red). The secondary structure elements are labelled and the potassium ion from the A chain is shown as a purple
sphere. (C) and (D) TheVapGmolecule coloured as above viewed parallel to the long axis of the barrel. It is apparent that the barrel is closed off by theb3–b4
and b7–b8 segments when viewed from above (C) and by the a1 helix when viewed from below (D). In (C) the potassium ion has been omitted for clarity
(For interpretation of the colour information in this ﬁgure legend, the reader is referred to the web version of the article.).
[(Fig._4)TD$FIG]
Fig. 4. Potassium coordination in the A molecule of VapG. (A) Electron density (2Fobs Fcalc) contoured at the 1s and 6s levels and displayed on the
potassium ion, shown as a purple sphere, and neighbouring residues shown in ball-and-stick representation and coloured by atom type (carbon, green;
nitrogen, blue; oxygen, red). (B) The bound potassium ion (K+) is shown as a purple spherewith residueswhich contribute ligands to themetal centre shown
in cylinder representation and with metal–ligand bonds shown as dashed lines. The bond lengths in A˚ are given.
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unlikely to be present in VapC or VapH (Fig. 1B). There is a
second buried water which is hydrogen bonded to the side
chain of Ser51 (Fig. 5A) and themain chain of residues Val49
and Thr134.
3.4. The protein surface
The distribution of ionisable, polar and apolar groups on
the surface of VapG is noticeably uneven (Fig. 5B and C).
The upper third of the molecule viewed as in Fig. 5, is
devoid of ionisable groups and the hydroxyl groups of
Ser131, Ser136, Thr50 and Tyr55 represent the only polar side
chain functional groups on this surface (Fig. 5B). Instead,
the surface is dominated by exposed apolar side chains
which give rise to an expansive hydrophobic surface area
(Figs. 5B and 6C) which is extended by several conserved
glycine residues which give this surface a ﬂat as well as a
neutral character. The lower reaches of themolecule on the
other hand are signiﬁcantly more polar. Seven of the
14 ionisable groups are located on or surrounding the
a-helix at the base of the molecule while the remainder is
located on a belt around the centre of the barrel (Fig. 5C).
The virulence-associated proteins are rich in glycine
residues and the b-barrel domain of VapG contains
20 glycines in its 103 residues (Fig. 1B). This compares
with the frequency of 7.4% for the occurrence of glycine
residues in proteins as a whole. The distribution of these
glycine residues is shown in Fig. 5D. The absence of a side
chain in glycine is associated with main chain conforma-
tional ﬂexibility and a proportion of these residues most
notably Gly64-Gly65-Gly66 facilitate sharp turns between
the secondary structure elements in the VapG protein
chain. Others such as the striking cluster of Gly74-Gly75 and
Gly137 to Gly139-Gly140-Gly41 on strands b3 and b8,
respectively, combine to create a ﬂat and rather featureless
protein surface. At many of the glycine positions, the side
chain R groups of a non-glycine residue would be inward-
facing and the presence of a Cb atomwould be expected to
disrupt the close packing in the protein core. Thus for
example, the glycines at positions 137, 139, 141 and
143 allow strand b8 to pack closely over the ‘aromatic
ladder’ with the polypeptide segment 136–144 making no
contribution to the protein core.
[(Fig._5)TD$FIG]
Fig. 5. Details of the structure of VapG. (A) Stereo view of the core of VapG. The protein backbone is represented as a worm tracing coloured in cyan and the
side chains of residues that are signiﬁcantly buried in the protein interior are shown in cylinder format and coloured by atom type (carbon, green; nitrogen,
blue; oxygen, red). Two buried water molecules are shown as red spheres. Hydrogen bonding interactions between the buried side chains and these waters
are shown as dashed lines. (B) The largely hydrophobic distal surface of VapG. The protein backbone is represented as a worm tracing colour ramped as in
Fig. 3. Residues whose side chains are directed towards the solvent are shown in ball-and-stick representation and coloured according to their side chain
type: non-polar aliphatic (Ala, Pro, Val, Leu, Ile), coral; aromatic (Trp, Tyr, Phe), light green; polar (Ser, Thr, Asn, Gln), gold; acidic (Glu, Asp) red; histidine,
light blue. The Ca atoms of glycine residues are shown as grey spheres. (C) The distribution of ionisable residues in VapG. The side chains of acidic and basic
residues are shown in cylinder format. (D) The distribution of the 20 glycine residues in VapG. The Ca atom of each glycine residue is shown as a grey sphere
(For interpretation of the colour information in this ﬁgure legend, the reader is referred to the web version of the article.).
Table 2
Comparison of Vap protein sequences and structures. The table shows the
pairwise percentage sequence identities over the b-barrel regions of the
Vap proteins (light grey shading) and the rmsD in Ca coordinate positions
deduced from the crystal structures (darker grey shading). For the VapG
structure, the comparisons refer to molecule A.
VapB VapD VapG
VapB - 56 57
VapD 0.94 - 61
VapG 0.96 1.25 -
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3.5. Structure comparisons with VapB and VapD
The structures of VapB, VapD and the two molecules of
VapG are compared in Table 2 and Fig. 6 (Geerds et al.,
2014; Whittingham et al., 2014). The A and B molecules of
VapG in the crystallographic asymmetric unit, coloured in
different shades of blue, superpose more closely than
either does onto VapB or VapD. Nevertheless, VapB, VapD
and VapG share the same fold and are closely superim-
posable. It is apparent that VapB is more similar to VapD
and VapG (lower pairwise rmsD values) than the latter pair
is to each other, presumably reﬂecting the extent of
sequence identity (Table 2). The molecules superimpose
most closely in their central waist when viewed as in
Fig. 6A, where the segments of structure form b-strands,
and in the lower third of the structure where the only
signiﬁcant difference in structure is the b2–b3 loop where
VapD and VapG contain one and ﬁve more residues than
VapB, respectively. Otherwise, such differences as exist
between pairs of structures are located in the loops at the
opposite end of the molecule and these are apparent in
Fig. 6B. One source of difference among the structures is
the aspartic acid residue at the beginning of strand b4 in
VapD (Whittingham et al., 2014). This residue plays
an important role in determining the conformation of
the b7–b8 loop in this protein by forming charge–dipole
interactionswithmain chain amides from four consecutive
residues in this loop. These interactions distort the
conformation of the b7–b8 loop away from that which
obtains in VapB and VapG. In VapB and VapG, the aspartate
is replaced by smaller apolar residues, Gly and Ala,
respectively, which allow the closer approach of the
[(Fig._6)TD$FIG]
Fig. 6. Comparison of the crystal structures of the three R. equi virulence-associated proteins. (A) and (B) The structures of VapG molecule A (blue), VapG
molecule B (light blue) VapD (red) and VapB (green) were overlaid using the SSM superpose routines in CCP4mg and the polypeptide backbones displayed
as worm tracings. The superposed protein chains are viewed from the side illustrating the whole molecules (A) and from above parallel to the long axis of
the barrel with the molecule clipped for clarity (B). (C) Electrostatic surface renderings of VapB, VapD and VapGwith positive electrostatic potential in blue
and negative electrostatic potential in red. The three molecules are viewed in two orientations which are illustrated by the ribbon tracing for VapG at the
left. The extended apolar surface previously noted for VapD and VapB is evident (For interpretation of the colour information in this ﬁgure legend, the reader
is referred to the web version of the article.).
T. Okoko et al. / Veterinary Microbiology 179 (2015) 42–52 49
b7–b8 loop. Elsewhere, the presence of Pro110 on the
b5–b6 loop of VapG contributes to differences in the
conformation of this loop relative to VapB and VapDwhere
the corresponding residue is Thr.
As shown in Fig. 6C, all three Vap proteins exhibit an
asymmetric distribution of ionisable/polar residues and
there is an amphipathic character to the molecules along
the axis of the barrel. The base of all three molecules is
richer in areas of both positive and negative electrostatic
potential while there is an extended apolar surface over
the dome at the top of the molecule (Geerds et al., 2014;
Whittingham et al., 2014).
4. Discussion
The virulence plasmid of R. equi has long been
recognised for its association with disease caused by this
bacterium and VapA has emerged as a primary plasmid-
encoded virulence determinant. VapA is the deﬁning
member of a family of proteins related by sequence and
which are encoded in multiple copies by three types of
virulence plasmid in R. equi, pVAPA which is primarily
associated with disease in horses, pVAPB which is
primarily associated with disease in pigs and pVAPN
which is primarily associated with bovine isolates
(Va´zquez-Boland et al., 2013). vap-family genes have also
been discovered in other bacterial genomes where they
occur in single copy. Here, they encode proteins that lack
recognisable secretion signal peptides and their functions
are unknown (Va´zquez-Boland et al., 2013; Whittingham
et al., 2014). As an immuno-dominant marker in infection
and as an essential virulence factor in R. equi disease in
horses, VapA has been a focus of research in this ﬁeld.
Despite these efforts, relatively little is known about the
cellular role of VapA, its biochemical activity, and its
functional relationship, if any, to the ﬁve plasmid-encoded
orthologues.
The structure of VapG determined in this work,
complements those of VapB and VapD determined
previously (Geerds et al., 2014; Whittingham et al.,
2014). The close similarity of the three structures is no
surprise given the high sequence identity and we can
predict with conﬁdence that the eight-stranded b-barrel
occurs in the other Vap proteins including VapA. In each of
the Vap proteins, theb-barrel domain is preceded by a 25–
65 residue amino terminal peptide of variable sequence
that is predicted to be natively disordered. Consistent with
this prediction, in the crystals of VapG and VapD, the
amino terminal region is present but not deﬁned in the
electron density maps indicating static or dynamic
disorder in the crystals.
So what then are the functional implications of the
crystal structures? An inspection of the surfaces of VapG,
VapB and VapD reveals no signiﬁcant depressions to
indicate the presence of a ligand-binding cavity or an
enzyme active site. Eight stranded barrel proteins with
partial similarity to the Vaps occur elsewhere in bacterial
cell surface/periplasmic proteins with roles in virulence.
For example, bradavidin from Bradyrhizobium japonicum
and PliC from Salmonella typhimurium function as a biotin
binding protein and a periplasmic lysozyme inhibitor
respectively (Leppiniemi et al., 2013; Leysen et al., 2011).
In both instances, the proteins have an anti-parallel all-
next-neighbour b-barrel topology b1–b2–b3–b4–b5–
b6–b7–b8. The absence of crossover strands lends these
barrels intrinsically more open structures, allowing one
end of the barrel to develop as a binding/active site with
the barrel interior forming the base of a ligand-binding
cavity. There is less potential for a binding site in the Vap
proteins due to the altered topology which leads to
segments (b3–b4 and b7–b8) crossing over, and closing
off, the top of the barrel (Fig. 3). At the opposing end, the
barrel is closed off by the a-helix.
Similarly, the barrel domains of VapB, VapD and VapG
have no obvious depressions or ridges on the protein
surface to suggest protein interaction sites. This does not
exclude the possibility that the Vaps are involved in
interactions with other proteins since protein–protein
recognition surfaces are variable in character (Janin et al.,
2008). Moreover, such interactions may be mediated by
the natively unfolded amino terminal regions and accom-
panied by a disorder-to-order transition upon interaction
with a cognate bacterial or host factor. Alternatively, it is
possible that VapA and the other Vap proteins have
functions, which are manifested following a conforma-
tional change in the protein. Conformational changes
frequently accompany the binding of small molecules to
proteins. For example, in the starvation sensor CodY of B.
subtilis, the branched chain amino acid binding site is
absent in the crystal structure of the unliganded protein, its
formation in the presence of ligand is accompanied by a
large spontaneous rearrangement of loops elaborated from
a b-sheet (Levdikov et al., 2009). Virulence factors in other
pathogens undergo pH-dependent conformational
changes. Indeed conformational changes in proteins
associated with the phagolysosome pathway are amongst
the largest to have been characterised by biophysical
methods and observed/inferred from crystal structures
(Bullough et al., 1994; Santelli et al., 2004). One example is
the protective antigen (PA) of Bacillus anthracis, the cell
entry component of the two-component toxins secreted by
the anthrax causing bacterium. Following receptor binding
on the host cell surface, PA assembles to form a heptameric
prepore that binds the partner toxin, lethal factor or
oedema factor, before being taken into the cell by
endocytosis. The lowering of the pH upon endosome
maturation, leads to protonation of a cluster of histidine
residues on PA (Santelli et al., 2004) and rearrangement of
a 75 residue largely disordered segment of the polypeptide
to form an extended pair ofb-strands linked by ab-turn. In
the heptamer, the result is a 14-stranded b-barrel which
forms a pore in the endosome membrane allowing the
lethal and oedema factors to gain access to the host cell
cytoplasmwhere they exert their toxic effects. In inﬂuenza
virus, the surface protein haemagglutinin (HA), which is
involved in cell surface binding and viral endocytosis,
undergoes a dramatic conformational change upon acidi-
ﬁcation of the endosome (Bullough et al., 1994). Here, a
cluster of aspartates becomes protonated as the pH is
lowered allowing a random coil segment of HA to refold as
an a-helix projecting the three amino terminal fusion
peptides in the HA trimer 100 A˚ towards the endosome
T. Okoko et al. / Veterinary Microbiology 179 (2015) 42–5250
membrane where they facilitate fusion of the viral and
endosome membranes and release of the viral contents
into host cell cytoplasm.
The Vap proteins of R. equi do not have a role in
endocytosis, instead they are secreted into the endosome
by the phagocytosed bacterium and they have simpler
structures than PA or HA. pH-induced activation of the Vap
proteins, and VapA in particular, is appealing conceptually
and vap gene expression is known to be induced in R. equi
grown in equine macrophages and this induction can be
mimicked by growth of bacteria at 37 8C at pH 5 under
conditions of metal limitation (Ren and Prescott, 2003).
However, a study of the maturation of R. equi-containing
vesicles in mouse macrophages suggested many of the
markers of the late endocytic stage were not acquired and
there was arrest after completion of the early endosome
stage (Fernandez-Mora et al., 2005). Speciﬁcally, the
proton pumping ATPase was not acquired and the vesicles
were not acidiﬁed. The prevailing view is that VapA has an
upstream role in preventing acidiﬁcation of the R. equi-
containing vacuole and therefore is unlikely to be
pH-activated.
A second question that may be posed concerns the
determinants of the VapA sequence/structure responsible
for its dominant role among the Vap proteins as a virulence
factor in foals. Despite their similarities, the Vaps can be
distinguished immunologically and it was reported that
antibodies that recognise VapA do not cross react with
recombinant Vaps C, D or E (Byrne et al., 2001). The
sequence variability at the N-terminus of the Vap proteins
has obvious potential for conferring differential function.
Equally, it is established that proteins that have a common
structural framework can perform diverse functions, thus,
the limited sequence and structural differences in the
b-barrel domains may allow the Vap proteins to make
selective interactions. In relation to virulence, VapA may
make interactionswith a host factor that leads to a block in
endosome maturation.
VapA is reported to be retained on the bacterial cell
surface, and this localisation may be selective since VapC,
VapD and VapE were shown to be secreted into the culture
supernatants (Byrne et al., 2001). The cell surface
presentation of VapA, perhaps as a complex with other
bacterial factors or surface glycolipids, may be important
in the virulence mechanism. It is also possible that the
selective virulence properties of VapA are related to
differential transcriptional regulation allowing the protein
to attain a threshold concentration at a critical point in the
life cycle of R. equi inside infected macrophages (Byrne
et al., 2008).
5. Conclusion
The Vap proteins of R. equi consist of b-barrel domains
with disordered regions at their N-termini. There are no
intrinsic or comparative features of the Vap protein
structures that provide clues to function. The structures
provide a framework for structure-function studies of
VapA but fuller understanding of R. equi virulence depends
on the future identiﬁcation of the interacting molecular
partners of the Vap proteins.
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